Genedx Holdings Corp Class A (WGS)
Genedx Holdings stock today
Genedx Holdings closed at $69.06 on October 30, 2026, down 2.76% on the day. Over the past year it returned -47.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.05 billion.
| Period | WGS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -4.5% | -0.9% |
| 3 months | +0.1% | +2.1% |
| Year to date | -46.9% | +11.7% |
| 1 year | -47.5% | +12.4% |
| 3 years | +2,487% | +88.5% |
| 5 years | -74.1% | +76.0% |
Key statistics
- Market value
- $2.05B
- Forward P/E
- 104.1
- Price / sales
- 4.5
- 52-week range
- $34.51 to $167.51
- Next report
- Nov 9, 2026
About Genedx Holdings
Provides genetic testing and genomic analysis services for clinical diagnostics.
Sector: Health Care
More on Genedx Holdings
- Financials: revenue, earnings and segmentsRevenue +40% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $259.32 today
No forecast, no recommendation. This page describes Genedx Holdings Corp Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.